GlassScriptPhysician profile
Donna M Valentini
NPI 1598762122
$1,703.47
in general payments reported to CMS, 2019-2025
14 companies · $14.37 in 2025
The $14.37 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $216 · 2021: $614 · 2022: $327 · 2023: $188 · 2024: $189 · 2025: $14.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $391.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $391.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $439.00 | 2021 | |
| Sun Pharmaceutical Industries INC. | $220.48 | 2020-2025 | Cequa |
| Oyster Point Pharma, INC. | $179.07 | 2022-2023 | Tyrvaya |
| Bausch & Lomb Americas INC. | $147.17 | 2024 | Infuse, Miebo |
| Novartis Pharmaceuticals Corporation | $143.55 | 2019-2023 | |
| Shire North American Group INC | $122.13 | 2019 | |
| Allergan, INC. | $111.42 | 2020 | |
| Abbvie INC. | $110.46 | 2022-2024 | Alphagan P, Lumigan, Vuity |
| Alcon Vision LLC | $63.89 | 2022-2024 | Total30 |
| Kala Pharmaceuticals, INC. | $48.79 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $37.23 | 2021 | |
| Menicon America INC | $31.99 | 2020 | |
| Genentech USA, INC. | $27.28 | 2023 | Vabysmo |
| Aerie Pharmaceuticals, INC. | $21.01 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Valentini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.